Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre study

Introduction: Pauci-immune crescentic glomerulonephritis (PICN) is an important cause of rapidly progressive renal failure. 10–40% of PICN cases have ANCA (antineutrophil cytoplasmic antibody) negative serology. The present study compared clinico-pathologic features, Brix’s renal risk score, Berden’...

Full description

Saved in:
Bibliographic Details
Main Authors: Pallav Gupta, Vinant Bhargava, Manish Malik, Anurag Gupta, Anil K. Bhalla, Ashwini Gupta, Vaibhav Tiwari, Devinder S. Rana, Ramesh L. Sapra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-07-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijpm.ijpm_604_22
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591242962141184
author Pallav Gupta
Vinant Bhargava
Manish Malik
Anurag Gupta
Anil K. Bhalla
Ashwini Gupta
Vaibhav Tiwari
Devinder S. Rana
Ramesh L. Sapra
author_facet Pallav Gupta
Vinant Bhargava
Manish Malik
Anurag Gupta
Anil K. Bhalla
Ashwini Gupta
Vaibhav Tiwari
Devinder S. Rana
Ramesh L. Sapra
author_sort Pallav Gupta
collection DOAJ
description Introduction: Pauci-immune crescentic glomerulonephritis (PICN) is an important cause of rapidly progressive renal failure. 10–40% of PICN cases have ANCA (antineutrophil cytoplasmic antibody) negative serology. The present study compared clinico-pathologic features, Brix’s renal risk score, Berden’s histopathological classes and differences in outcome between ANCAnegative vs ANCA positive PICN patients. Materials and Methods: Sixty-one patients of biopsy-proven PICN were studied. Biochemical findings and ANCA serology were recorded. Renal biopsy slides were reviewed along with direct immunofluorescence. Clinical and histological features were compared between ANCA negative and positive PICN using the Man Whitney U test and Chi-square test. Patients were compared for distribution in Berden’s histological classes and Brix’s renal risk categories. Patient and renal survival were compared using Kaplan-Meier survival analysis. Results: ANCA negative PICN patients were younger (44.9 ± 16.5 years vs 53.6 ± 15.1 years, P = 0.049). Nasal (0 vs 18%, P = 0.035) and pulmonary involvement (9% vs 38%, P = 0.014) were lower in ANCA negative group. Both ANCA groups had similar renal biochemical profiles, percentage normal glomeruli, 16.3 ± 18.2 vs 21.7 ± 20.4 and percentage glomeruli with crescents, 64.5 ± 28.1 vs 64.3 ± 27.1. Twenty-seven per cent of ANCA negative cases fell in the sclerotic class in Berden’s classification vs just 2.5% in ANCA positive group (p = 0.037) without significant difference in Brix’s renal risk categories (p = 0.329). Thirteen per cent of ANCA negative patients achieved complete remission on treatment compared to 33% in ANCA positive patients. Patient survival and overall probability of progressing to ESRD were similar in the two groups. Conclusion: ANCA negative PICN cases present at younger ages. Nasal and pulmonary involvement is uncommon in these patients. Patient survival and progression to ESRD are similar in both ANCA groups.
format Article
id doaj-art-851ff254b3f94dbea75aa20757bc8057
institution Kabale University
issn 0377-4929
0974-5130
language English
publishDate 2023-07-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj-art-851ff254b3f94dbea75aa20757bc80572025-01-22T15:10:02ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49290974-51302023-07-01671869110.4103/ijpm.ijpm_604_22Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre studyPallav GuptaVinant BhargavaManish MalikAnurag GuptaAnil K. BhallaAshwini GuptaVaibhav TiwariDevinder S. RanaRamesh L. SapraIntroduction: Pauci-immune crescentic glomerulonephritis (PICN) is an important cause of rapidly progressive renal failure. 10–40% of PICN cases have ANCA (antineutrophil cytoplasmic antibody) negative serology. The present study compared clinico-pathologic features, Brix’s renal risk score, Berden’s histopathological classes and differences in outcome between ANCAnegative vs ANCA positive PICN patients. Materials and Methods: Sixty-one patients of biopsy-proven PICN were studied. Biochemical findings and ANCA serology were recorded. Renal biopsy slides were reviewed along with direct immunofluorescence. Clinical and histological features were compared between ANCA negative and positive PICN using the Man Whitney U test and Chi-square test. Patients were compared for distribution in Berden’s histological classes and Brix’s renal risk categories. Patient and renal survival were compared using Kaplan-Meier survival analysis. Results: ANCA negative PICN patients were younger (44.9 ± 16.5 years vs 53.6 ± 15.1 years, P = 0.049). Nasal (0 vs 18%, P = 0.035) and pulmonary involvement (9% vs 38%, P = 0.014) were lower in ANCA negative group. Both ANCA groups had similar renal biochemical profiles, percentage normal glomeruli, 16.3 ± 18.2 vs 21.7 ± 20.4 and percentage glomeruli with crescents, 64.5 ± 28.1 vs 64.3 ± 27.1. Twenty-seven per cent of ANCA negative cases fell in the sclerotic class in Berden’s classification vs just 2.5% in ANCA positive group (p = 0.037) without significant difference in Brix’s renal risk categories (p = 0.329). Thirteen per cent of ANCA negative patients achieved complete remission on treatment compared to 33% in ANCA positive patients. Patient survival and overall probability of progressing to ESRD were similar in the two groups. Conclusion: ANCA negative PICN cases present at younger ages. Nasal and pulmonary involvement is uncommon in these patients. Patient survival and progression to ESRD are similar in both ANCA groups.https://journals.lww.com/10.4103/ijpm.ijpm_604_22anca negativecrescentichistologyoutcomespauci-immune
spellingShingle Pallav Gupta
Vinant Bhargava
Manish Malik
Anurag Gupta
Anil K. Bhalla
Ashwini Gupta
Vaibhav Tiwari
Devinder S. Rana
Ramesh L. Sapra
Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre study
Indian Journal of Pathology and Microbiology
anca negative
crescentic
histology
outcomes
pauci-immune
title Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre study
title_full Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre study
title_fullStr Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre study
title_full_unstemmed Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre study
title_short Comparison of Clinico-pathologic features and outcomes of ANCA negative and ANCA positive pauci immune crescentic glomerulonephritis: A single centre study
title_sort comparison of clinico pathologic features and outcomes of anca negative and anca positive pauci immune crescentic glomerulonephritis a single centre study
topic anca negative
crescentic
histology
outcomes
pauci-immune
url https://journals.lww.com/10.4103/ijpm.ijpm_604_22
work_keys_str_mv AT pallavgupta comparisonofclinicopathologicfeaturesandoutcomesofancanegativeandancapositivepauciimmunecrescenticglomerulonephritisasinglecentrestudy
AT vinantbhargava comparisonofclinicopathologicfeaturesandoutcomesofancanegativeandancapositivepauciimmunecrescenticglomerulonephritisasinglecentrestudy
AT manishmalik comparisonofclinicopathologicfeaturesandoutcomesofancanegativeandancapositivepauciimmunecrescenticglomerulonephritisasinglecentrestudy
AT anuraggupta comparisonofclinicopathologicfeaturesandoutcomesofancanegativeandancapositivepauciimmunecrescenticglomerulonephritisasinglecentrestudy
AT anilkbhalla comparisonofclinicopathologicfeaturesandoutcomesofancanegativeandancapositivepauciimmunecrescenticglomerulonephritisasinglecentrestudy
AT ashwinigupta comparisonofclinicopathologicfeaturesandoutcomesofancanegativeandancapositivepauciimmunecrescenticglomerulonephritisasinglecentrestudy
AT vaibhavtiwari comparisonofclinicopathologicfeaturesandoutcomesofancanegativeandancapositivepauciimmunecrescenticglomerulonephritisasinglecentrestudy
AT devindersrana comparisonofclinicopathologicfeaturesandoutcomesofancanegativeandancapositivepauciimmunecrescenticglomerulonephritisasinglecentrestudy
AT rameshlsapra comparisonofclinicopathologicfeaturesandoutcomesofancanegativeandancapositivepauciimmunecrescenticglomerulonephritisasinglecentrestudy